Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-020045·BridgeBio Pharma, Inc.
Schedule 13G ownership disclosure
BRIDGEBIO PHARMA INC
Common Stock, par value $0.001 per share · CUSIP: 10806X102
Event date: 2024-12-31
- Filing-level shares
- 10,466,712
- Percent of class
- 5.41%
- NEIL KUMAR
Shares: 10,466,712 · Class: 5.41%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020045
- Form type
- SCHEDULE 13G/A
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership